Hence, preventing PD-1 interactions with its ligands PD-L1 and PD-L2 in the tumor microenvironment is expected to restore the cytotoxic functions of exhausted tumor-specific T cells and has achieved significant success in the management of advanced stage solid tumors. This evidence concerns the gene PDCD1LG2 and neoplasm.